7-124825358-C-T
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_015450.3(POT1):c.1687-1G>A variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.00000209 in 1,434,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_015450.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POT1 | NM_015450.3 | c.1687-1G>A | splice_acceptor_variant, intron_variant | ENST00000357628.8 | NP_056265.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POT1 | ENST00000357628.8 | c.1687-1G>A | splice_acceptor_variant, intron_variant | 2 | NM_015450.3 | ENSP00000350249.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000420 AC: 1AN: 238194Hom.: 0 AF XY: 0.00000776 AC XY: 1AN XY: 128906
GnomAD4 exome AF: 0.00000209 AC: 3AN: 1434684Hom.: 0 Cov.: 26 AF XY: 0.00000280 AC XY: 2AN XY: 713970
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Tumor predisposition syndrome 3 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2022 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 139521). Disruption of this splice site has been observed in individual(s) with melanoma (PMID: 24686849). This variant is present in population databases (rs587777473, gnomAD 0.0009%). This sequence change affects an acceptor splice site in intron 17 of the POT1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in POT1 are known to be pathogenic (PMID: 32155570). - |
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2014 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at